| Dr Gordon Albert Shields, MD | |
|
302 Merchants Walk Ste 100, Tuscaloosa, AL 35406-2291 | |
| (205) 523-9300 | |
| (205) 523-9301 |
| Full Name | Dr Gordon Albert Shields |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 24 Years |
| Location | 302 Merchants Walk Ste 100, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922059997 | NPI | - | NPPES |
| 009994165 | Medicaid | AL | |
| 51000907 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 00026424 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alabama Ear, Nose And Throat Specialists, Llc | 7719104504 | 5 |
News Archive
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company's methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient's breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.
A spin-out from the University of Helsinki, Valo Therapeutics is developing novel oncolytic viral vaccines for the treatment of multiple forms of cancer.
› Verified 1 days ago
| Entity Name | Alabama Ear, Nose & Throat Specialists, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023421468 PECOS PAC ID: 7719104504 Enrollment ID: O20140819002191 |
News Archive
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company's methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient's breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.
A spin-out from the University of Helsinki, Valo Therapeutics is developing novel oncolytic viral vaccines for the treatment of multiple forms of cancer.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gordon Albert Shields, MD 302 Merchants Walk 100, Tuscaloosa, AL 35406-2291 Ph: (205) 523-9300 | Dr Gordon Albert Shields, MD 302 Merchants Walk Ste 100, Tuscaloosa, AL 35406-2291 Ph: (205) 523-9300 |
News Archive
Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.
The cholesterol-lowering drug simvastatin appears to reduce spinal cord injury caused by oxygen deprivation in experimental animals, according to a study in the September issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
Cytori Therapeutics today received U.S. Patent No. 7,651,684 (the ‘684 patent) which covers the Company's methods for delivering adipose-derived stem and regenerative cell-enriched fat grafts into patients. The ‘684 patent specifically covers cell-enriched fat grafts to treat soft-tissue defects and urinary incontinence. In addition, the ‘684 patent covers methods for delivering cell-enriched fat grafts to a patient's breast, wrinkles, lips, under the eyes, cheeks, chin, and other parts of the body.
A spin-out from the University of Helsinki, Valo Therapeutics is developing novel oncolytic viral vaccines for the treatment of multiple forms of cancer.
› Verified 1 days ago
Mr. James Edgar Shotts Jr., MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. Lee Headley Loftin, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. Gary Mathers Lake Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Mr. David Bruce Rosenstiel, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 | |
Dr. Salem K David Jr., M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1224 Mcfarland Blvd Ne, Suite A, Tuscaloosa, AL 35406 Phone: 205-759-9930 Fax: 205-759-9931 | |
Dr. Craig Michael Benoit, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 302 Merchants Walk, Suite 100, Tuscaloosa, AL 35406 Phone: 205-523-9300 Fax: 205-523-9301 | |
Mr. James Hodo Walburn, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1300 Mcfarland Blvd Ne, Ste 150, Tuscaloosa, AL 35406 Phone: 205-758-9041 Fax: 205-345-8328 |